Search Results - "A. I. Kaminny"

FAMILIAL DYSBETALIPOPROTEINEMIA (TYPE III HYPERLIPOPROTEINEMIA) by Malyshev, P. P., Tyurina, A. V., Rozhkova, T. A., Zubareva, M. Y., Amelyushkina, V. A., Shuvalova, Y. A., Rebrikov, D. V., Kaminny, A. I.

“…The aim of this work was to describe a series of cases of familial dysbetalipoproteinaemia (FD) - a rare recessive disorder of lipid metabolism. The study…”
Get full text

Effects of combined therapy with atorvastatin and polyunsaturated omega-3 fatty acids on lipid profile, lipoprotein-associated phospholipase A2 and thromboxane by G. F. Piksina, Yu. A. Shuvalova, V. I. Kaminnaya, Yu. V. Dotsenko, V. N. Titov, V. V. Kukharchuk, A. I. Kaminny

“…Aim. To study the effects of the combined therapy with atorvastatin and polyunsaturated omega-3 fatty acids (omega-3 PUFA) on lipid profile,…”
Get full text

Antioxidant system gene polymorphism and restenosis risk after coronary stenting by Yu. A. Shuvalova, A. N. Meshkov, A. I. Kaminny, A. N. Samko, R. O. Shirokov, D. V. Stambolsky, V. V. Kukharchuk

“…Aim. To study the links between four polymorphisms of three antioxidant enzymes (catalase, paraoxonase, endothelial NO synthase) and restenosis risk after…”
Get full text

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions by Yu. A. Shuvalova, A. N. Meshkov, A. I. Kaminny, G. F. Piksina, V. V. Kukharchuk

“…Coronary restenosis remains the main problem for effectiveness of percutaneous transluminal coronary angioplasty (PCA) and coronary stenting (CS). The aim of…”
Get full text

ASSESSMENT OF THE EFFECT OF RS2230806 ALLELIC VARIANT IN THE ABCA1 GENE ON THE LIPID-LOWERING EFFECTS OF ATORVASTATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA by G. P. Smirnov, T. A. Rozhkova, M. Yu. Zubareva, Yu. A. Shuvalova, D. V. Rebrikov, A. I. Kaminny, V. N. Titov, V. V. Kukharchuk, P. P. Malyshev

“…Objective: to evaluate the effect of rs2230806 variant in the ABCA1 gene on lipid and apolipoprotein (apo)A-I and apoB levels after the atorvastatin treatment…”
Get full text

Antioxidant status and restenosis after stenting of coronary arteries by Kaminnyĭ, A I, Shuvalova, Iu A, Lankin, V Z, Piksina, G F, Shirokov, R O, Samko, A N, Kukharchuk, V V

“…To investigate possibility of effect of antioxidant status on severity of restenosis of coronary arteries after transluminal coronary angioplasty with…”
Get more information

Antioxidant agent Probucol beneficial influence on incidence and severity of coronary artery restenosis after transluminal balloon coronary angioplasty by A. I. Kaminny, V. Z. Lankin, V. I. Kaminnaya, E. I. Perepelitsa, Yu. A. Shuvalova, A. N. Samko, V. V. Kukharchuk

“…Aim. To study perspectives of reducing incidence and severity of coronary artery (CA) restenosis by adding a low dose of antioxidant agent Probucol (250 mg/d)…”
Get full text

Assessment of hypolipidemic efficacy and safety of various doses of atorvastatin by Kukharchuk, V V, Kaminnĭ, A I

Get more information